Trial intelligence / Profile preview

Crossover Study of Enteric-Coated Nicystagon in Japanese Adults with Cystinosis

jRCTs031250831Recruiting

Sponsor
National Center for Global Health and Medicine
Start
May 2026
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of cysteamine in cystinosis (3 arms), sponsored by National Center for Global Health and Medicine. Primary endpoint: Leukocyte cystine concentration at 5 hours after administration. Started May 2026; status: recruiting.

02

Drugs

cysteamine
03

Conditions

cystinosis

Beyond the preview

Go deeper on jRCTs031250831.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs031250831.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call